i
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) : information and guidance for clinicians
-
June 13, 2013
Series: COCA Conference Call
Details:
-
Personal Author:
-
Corporate Authors:Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Clinician Outreach and Communication Activity. ; National Center for Immunization and Respiratory Diseas (U.S.). Division of Viral Diseases. ; National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion.
-
Description:Thursday, June 13, 2013
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a newly identified virus that can cause severe acute respiratory illness and death. MERS cases have been linked to the Middle East, and there is documented spread of the virus internationally. So far, no cases of MERS have been reported in the United States. However, clinicians need to remain vigilant. Epidemiologic investigations have demonstrated that this unique virus spreads from person to person during close contact, such as within families and healthcare facilities. Clinicians have a critical role in recognizing and managing suspect cases of MERS. During this COCA call, a CDC subject matter expert will discuss the clinical signs, epidemiology and infection control recommendations for MERS-CoV.
06_13_13_merscov_final.pdf
-
Content Notes:Emergence of a Novel Coronavirus in the Arabian Peninsula, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) / Susan I. Gerber. – Interim infection preention and control recommendations for hospitalized patients / Alexander Kallen.
-
Subject:
-
Series:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
No Additional Files
More +